Boston Scientific Corp. is stepping up efforts to enter the growing fractional flow reserve interventional cardiology market, inking a development agreement with Japanese guidewire-maker Asahi Int
The year 2014 was a heady one for medtech M&A, with bigger deals and more invested in them than ever before – $89.3 billion, according to Informa’s Strategic Transactions . A lot of the 2014 M&A impe